Cited 0 times in Scipus Cited Count

Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody

DC Field Value Language
dc.contributor.authorJoung, YK-
dc.contributor.authorSon, S-
dc.contributor.authorJang, JY-
dc.contributor.authorKwon, MH-
dc.contributor.authorPark, KD-
dc.date.accessioned2013-04-23T05:23:43Z-
dc.date.available2013-04-23T05:23:43Z-
dc.date.issued2012-
dc.identifier.issn0724-8741-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/7867-
dc.description.abstractPURPOSE: Cytoplasmic delivery of a monoclonal antibody (mAb) with nucleic acid-hydrolyzing activity (3D8 scFv) using poly(lactic-co-glycolic acid) nanoparticles (PLGA NPs) was investigated for persistent anti-viral effect.



METHODS: 3D8 scFv-loaded PLGA (3D8-PLGA) NPs were prepared via a double emulsion method that was previously optimized. Flow cytometry and confocal microscopy was carried out to confirm the cellular uptake and cytoplasmic localization. immunochemical and fluorescence resonance energy transfer (FRET) assays tested the cytoplasmic release and hydrolyzing effect of 3D8 scFv, respectively. Anti-viral activity test was performed using MTT assay with vesicular stomatitis virus (VSV)-infected HeLa cells.



RESULTS: 3D8-PLGA NPs were much more effectively taken into cells in dose- and time-dependent manner and localized in the cytosolic region, compared to free 3D8 scFv. 3D8 scFv was released and hydrolyzed RNAs in the cytoplasm, exhibiting the maxima at a period of time (12-24 h). Anti-viral activity test revealed that 3D8-PLGA NP has dose- and time-dependent anti-viral effect and the maximum effect at the dose of 2 mg/ml and the incubation of 3 days.



CONCLUSIONS: Cytoplasmic delivery of 3D8 scFv via PLGA NPs could enhance the viability of infected cells in sustained manner due to preserved activity, much improved cellular uptake and sustained release.
-
dc.language.isoen-
dc.subject.MESHAnimals-
dc.subject.MESHAntibodies, Monoclonal-
dc.subject.MESHAntiviral Agents-
dc.subject.MESHCell Line, Tumor-
dc.subject.MESHCell Survival-
dc.subject.MESHCytosol-
dc.subject.MESHDelayed-Action Preparations-
dc.subject.MESHDrug Carriers-
dc.subject.MESHDrug Delivery Systems-
dc.subject.MESHEmulsions-
dc.subject.MESHHCT116 Cells-
dc.subject.MESHHeLa Cells-
dc.subject.MESHHumans-
dc.subject.MESHHydrolysis-
dc.subject.MESHLactic Acid-
dc.subject.MESHMice-
dc.subject.MESHNanoparticles-
dc.subject.MESHNucleic Acids-
dc.subject.MESHPolyglycolic Acid-
dc.subject.MESHRNA-
dc.titleSustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody-
dc.typeArticle-
dc.identifier.pmid22139535-
dc.contributor.affiliatedAuthor권, 명희-
dc.type.localJournal Papers-
dc.identifier.doi10.1007/s11095-011-0633-0-
dc.citation.titlePharmaceutical research-
dc.citation.volume29-
dc.citation.number4-
dc.citation.date2012-
dc.citation.startPage932-
dc.citation.endPage942-
dc.identifier.bibliographicCitationPharmaceutical research, 29(4). : 932-942, 2012-
dc.identifier.eissn1573-904X-
dc.relation.journalidJ007248741-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Microbiology
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse